Eduardo Chen, MD
Physical Medicine and Rehabilitation · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Texas S9858Physician License · since 2021 · expires 2026-02-28Delinquent - Incomplete RegistrationNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$152,277
Medicare paid this office $152,277 for 359 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 223 | $38,532 | $93 |
| New patient visit (45+ min) | 170 | $21,044 | $124 |
| Short return visit (20+ min) | 210 | $19,987 | $66 |
| Injection of substance into lower spine canal using imaging guidance | 118 | $9,796 | $70 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 261 | $6,937 | $13 |
See all 22 services
| Return visit (30+ min) | 223 | $38,532 | $93 |
| New patient visit (45+ min) | 170 | $21,044 | $124 |
| Short return visit (20+ min) | 210 | $19,987 | $66 |
| Injection of substance into lower spine canal using imaging guidance | 118 | $9,796 | $70 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 261 | $6,937 | $13 |
| Muscle electrical test | 32 | $4,861 | $76 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 46 | $4,501 | $90 |
| Injection of substance into middle or upper spine canal using imaging guidance | 35 | $4,171 | $77 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 20 | $3,965 | $198 |
| Nerve test | 18 | $3,881 | $216 |
| Nerve test | 14 | $2,745 | $196 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $2,718 | $88 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 26 | $2,045 | $76 |
| Aspiration and/or injection of fluid from large joint | 30 | $1,997 | $59 |
| X-ray of lower and sacral spine, minimum of 4 views | 42 | $1,698 | $39 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 37 | $1,571 | $39 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 18 | $1,528 | $49 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 20 | $1,386 | $45 |
| Aspiration and/or injection of fluid from large joint | 23 | $1,071 | $37 |
| Fluoroscopic guidance for needle placement | 30 | $808 | $20 |
| X-ray of upper spine, 4-5 views | 18 | $669 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $81 | None |
Who their Medicare patients are
359 Original Medicare patients in 2024. Average age 73 · Under 65 3% · 85 and older 5% · Women 56% · Health risk score 1.06. At or below the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Coronary heart disease 33% · Diabetes 31% · Depression 24% · Chronic kidney disease 21% · Atrial fibrillation 19% · Heart failure 15% · Cancer 14% · COPD 9% · Stroke 8%.
The office billed $1,135,258, Medicare allowed $200,914 and paid $152,277; for 2,722 services of 59 kinds; $2,303 of it was for drugs given in the office and $149,974 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 359 | 2,722 | 73 | 1.06 | $1,135,258 | $152,277 |
| 2023 | 364 | 1,953 | 73 | 1.09 | $1,209,996 | $156,987 |
| 2022 | 227 | 1,202 | 73 | 1.13 | $661,790 | $96,272 |
| 2021 | 112 | 1,761 | 70 | 1.20 | $1,071,904 | $117,287 |
| 2020 | 130 | 1,476 | 69 | 1.28 | $514,111 | $87,422 |
| 2019 | 42 | 95 | 66 | 1.33 | $18,757 | $5,680 |
| 2018 | 32 | 37 | 72 | 2.10 | $9,409 | $2,583 |
| 2017 | 121 | 794 | 78 | 1.81 | $321,681 | $65,571 |
| 2016 | 39 | 133 | 80 | 1.80 | $52,690 | $10,724 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Return visit (30+ min) | 221 | $40,755 | $94 |
| New patient visit (45+ min) | 220 | $26,370 | $120 |
| Short return visit (20+ min) | 190 | $20,533 | $65 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 15 | $11,185 | $746 |
| Injection of substance into lower spine canal using imaging guidance | 116 | $10,606 | $76 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 25 | $5,963 | $206 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 32 | $5,323 | $99 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 24 | $3,632 | $47 |
| Injection of substance into middle or upper spine canal using imaging guidance | 30 | $3,351 | $80 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 31 | $2,998 | $57 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 26 | $2,571 | $92 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 24 | $1,864 | $72 |
| X-ray of lower and sacral spine, minimum of 4 views | 49 | $1,839 | $38 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 23 | $1,715 | $71 |
| Aspiration and/or injection of fluid from large joint | 29 | $1,382 | $41 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,359 | $50 |
| Fluoroscopic guidance for needle placement | 39 | $978 | $21 |
| Evaluation for physical therapy, typically 20 minutes | 16 | $899 | $56 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 21 | $883 | $38 |
| X-ray of upper spine, 4-5 views | 18 | $730 | $41 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 13 | $271 | $16 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $63 | None |
2022: 20 services
| New patient visit (45+ min) | 201 | $26,003 | $129 |
| Return visit (30+ min) | 124 | $22,394 | $100 |
| Short return visit (20+ min) | 92 | $9,537 | $72 |
| Injection of substance into lower spine canal using imaging guidance | 56 | $5,388 | $79 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 22 | $3,536 | $91 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $2,619 | $164 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 15 | $2,281 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 20 | $2,053 | $55 |
| X-ray of lower and sacral spine, minimum of 4 views | 47 | $1,940 | $41 |
| Injection of substance into middle or upper spine canal using imaging guidance | 17 | $1,910 | $87 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 22 | $1,811 | $72 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $1,537 | $96 |
| X-ray of upper spine, 4-5 views | 22 | $952 | $43 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 11 | $947 | $47 |
| Aspiration and/or injection of fluid from large joint | 19 | $806 | $37 |
| Fluoroscopic guidance for needle placement | 26 | $731 | $22 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $586 | $42 |
| Aspiration and/or injection of fluid from large joint | 11 | $574 | $52 |
| X-ray of shoulder, minimum of 2 views | 12 | $340 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $43 | None |
2021: 20 services
| Return visit (30+ min) | 94 | $39,347 | $100 |
| Nerve test | 40 | $10,810 | $240 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 58 | $8,400 | $75 |
| Muscle electrical test | 40 | $7,250 | $81 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 21 | $5,965 | $170 |
| New patient visit (45+ min) | 42 | $5,314 | $127 |
| Injection of substance into lower spine canal using imaging guidance | 42 | $4,700 | $77 |
| Fluoroscopic guidance for needle placement | 21 | $3,865 | $90 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | $3,858 | $77 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 19 | $3,129 | $130 |
| Short return visit (20+ min) | 22 | $2,295 | $72 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,965 | $50 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 57 | $1,918 | $18 |
| Testing for presence of drug, by chemistry analyzers | 28 | $1,864 | $62 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 18 | $1,585 | $83 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 16 | $1,487 | $48 |
| Injection of substance into middle or upper spine canal using imaging guidance | 12 | $1,106 | $85 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $742 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | $300 | None |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 27 | $33 | $0 |
2020: 21 services
| Return visit (30+ min) | 72 | $13,087 | $81 |
| Short return visit (20+ min) | 86 | $11,031 | $52 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 23 | $6,737 | $173 |
| Nerve test | 15 | $4,599 | $242 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 23 | $4,268 | $48 |
| Injection of substance into lower spine canal using imaging guidance | 36 | $3,866 | $81 |
| New patient visit (45+ min) | 32 | $3,837 | $120 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 33 | $3,760 | $114 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 20 | $3,423 | $127 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $2,739 | $68 |
| Muscle electrical test | 15 | $2,684 | $71 |
| Testing for presence of drug, by chemistry analyzers | 38 | $2,314 | $61 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 11 | $2,062 | $86 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 14 | $1,478 | $42 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 13 | $1,455 | $43 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 11 | $1,189 | $50 |
| Fluoroscopic guidance for needle placement | 12 | $1,189 | $79 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 11 | $1,176 | $49 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 12 | $1,091 | $91 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $511 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | $327 | None |
2019: 1 service
| Short return visit (20+ min) | 29 | $1,989 | $57 |
2018: 2 services
| New patient visit (30+ min) | 24 | $1,909 | $80 |
| Short return visit (20+ min) | 11 | $591 | $49 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $28,784 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $19,995 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,394 | $185 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $4,132 | $125 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,769 | $66 |
2016: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $5,791 | $65 |
Medicaid work
$1,737 in 2022
Medicaid paid $1,737 for 18 billed services this clinician did in 2022, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 18 | $1,737 |
| 2022 | 18 | 1 | 16 | $1,737 |
| 2021 | 651 | 3 | 44 | $53,187 |
| 2020 | 700 | 17 | 60 | $32,216 |
| 2019 | 80 | 2 | 28 | $5,014 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 428 | $43,399 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 103 | $7,350 |
| OFF/OP EST MAY X REQ PHY/QHP | 120 | $2,439 |
2020
| Short return visit (20+ min) | 330 | $19,630 |
| Return visit (30+ min) | 123 | $11,760 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 12 | $746 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $64 |
| Antidepressants, tricyclic and other cyclicals; 3-5 | 12 | $13 |
| MEASURE BLOOD OXYGEN LEVEL | 45 | $4 |
| Antidepressants, tricyclic and other cyclicals; 1 or 2 | 12 | $0 |
| Benzodiazepines; 1-12 | 12 | $0 |
| Buprenorphine | 12 | $0 |
| Measurement of cocaine | 12 | $0 |
| Heroin metabolite | 12 | $0 |
| Measurement of methadone | 12 | $0 |
2019
| Short return visit (20+ min) | 64 | $3,445 |
| Return visit (30+ min) | 16 | $1,569 |
Drugs they prescribed that Part D paid
$6,404
Pharmacies billed $6,404 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (77 of 707) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%.
707 generic and 0 brand-name prescriptions · $6,404 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 226 | $1,256 | $6 |
| Celecoxib | 48 | $948 | $20 |
| Tizanidine | 98 | $904 | $9 |
| Cyclobenzaprine | 48 | $685 | $14 |
| Pregabalin | 33 | $559 | $17 |
See all 13 drugs
| Gabapentin | 226 | $1,256 | $6 |
| Celecoxib | 48 | $948 | $20 |
| Tizanidine | 98 | $904 | $9 |
| Cyclobenzaprine | 48 | $685 | $14 |
| Pregabalin | 33 | $559 | $17 |
| Diclofenac | 17 | $322 | $19 |
| Methylprednisolone | 48 | $269 | $6 |
| Tramadol | 26 | $264 | $10 |
| Acetaminophen-Codeine | 23 | $242 | $11 |
| Meloxicam | 57 | $189 | $3 |
| Hydrocodone-Acetaminophen | 17 | $138 | $8 |
| Duloxetine | 14 | $67 | $5 |
| Oxycodone | 11 | $56 | $5 |
Year by year
| 2024 | 707 | 229 | 11% (77) | 0% | $6,404 |
| 2023 | 480 | 178 | 11% (53) | None | $7,010 |
| 2022 | 291 | 123 | 6% (17) | None | $3,759 |
| 2021 | 474 | 120 | 18% (86) | None | $11,479 |
| 2020 | 997 | 187 | 27% (267) | 6% | $44,628 |
| 2019 | 99 | 46 | 32% (32) | None | $2,226 |
| 2018 | 272 | 68 | 10% (28) | None | $10,362 |
| 2017 | 378 | 94 | 10% (39) | None | $18,175 |
| 2016 | 147 | 33 | 13% (19) | 14% | $5,633 |
| 2015 | 62 | 19 | 0% (0) | None | $1,160 |
| 2014 | 117 | 33 | None | None | $4,218 |
| 2013 | 14 | None | 0% (0) | None | $695 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Tizanidine | 94 | $1,430 | $15 |
| Gabapentin | 147 | $1,187 | $8 |
| Celecoxib | 21 | $633 | $30 |
| Pregabalin | 15 | $384 | $26 |
| Meloxicam | 57 | $334 | $6 |
| Cyclobenzaprine | 12 | $276 | $23 |
| Methylprednisolone | 23 | $235 | $10 |
| Duloxetine | 13 | $172 | $13 |
| Hydrocodone-Acetaminophen | 11 | $170 | $15 |
| Oxycodone | 16 | $143 | $9 |
| Naproxen | 16 | $82 | $5 |
| Tramadol | 12 | $52 | $4 |
2022: 6 drugs
| Gabapentin | 97 | $840 | $9 |
| Tizanidine | 62 | $803 | $13 |
| Methylprednisolone | 22 | $233 | $11 |
| Cyclobenzaprine | 12 | $198 | $16 |
| Meloxicam | 28 | $183 | $7 |
| Duloxetine | 12 | $161 | $13 |
2021: 10 drugs
| Pregabalin | 30 | $2,811 | $94 |
| Gabapentin | 96 | $1,259 | $13 |
| Tizanidine | 98 | $1,050 | $11 |
| Hydrocodone-Acetaminophen | 47 | $698 | $15 |
| Baclofen | 14 | $547 | $39 |
| Diclofenac | 19 | $290 | $15 |
| Cyclobenzaprine | 22 | $189 | $9 |
| Tramadol | 18 | $186 | $10 |
| Meloxicam | 43 | $178 | $4 |
| Ibuprofen | 11 | $59 | $5 |
2020: 16 drugs
| Oxycontin | 27 | $12,468 | $462 |
| Pregabalin | 40 | $2,715 | $68 |
| Tizanidine | 208 | $2,471 | $12 |
| Gabapentin | 195 | $2,261 | $12 |
| Hydrocodone-Acetaminophen | 109 | $1,203 | $11 |
| Oxycodone | 35 | $828 | $24 |
| Meloxicam | 78 | $613 | $8 |
| Tramadol | 44 | $438 | $10 |
| Duloxetine | 19 | $429 | $23 |
| Diclofenac | 19 | $305 | $16 |
| Baclofen | 13 | $296 | $23 |
| Cyclobenzaprine | 31 | $265 | $9 |
| Amitriptyline | 39 | $210 | $5 |
| Oxycodone-Acetaminophen | 14 | $185 | $13 |
| Topiramate | 19 | $155 | $8 |
| Ibuprofen | 14 | $133 | $10 |
2019: 3 drugs
| Gabapentin | 22 | $199 | $9 |
| Tizanidine | 25 | $198 | $8 |
| Hydrocodone-Acetaminophen | 12 | $168 | $14 |
2018: 5 drugs
| Atorvastatin | 16 | $228 | $14 |
| Gabapentin | 17 | $199 | $12 |
| Warfarin | 12 | $174 | $14 |
| Metoprolol | 17 | $114 | $7 |
| Metformin | 11 | $68 | $6 |
2017: 8 drugs
| Gabapentin | 28 | $194 | $7 |
| Atorvastatin | 14 | $147 | $10 |
| Oxycodone | 14 | $103 | $7 |
| Hydrocodone-Acetaminophen | 14 | $97 | $7 |
| Pantoprazole | 16 | $94 | $6 |
| Amlodipine Besylate | 15 | $69 | $5 |
| Lisinopril | 14 | $62 | $4 |
| Metoprolol | 14 | $52 | $4 |
2016: 1 drug
| Atorvastatin | 13 | $141 | $11 |
Money from drug and device companies
$3,728 in 2025
| 2025 | 7 | 40 | $378 | $3,728 |
| 2024 | 8 | 41 | None | $2,281 |
| 2023 | 5 | 13 | None | $858 |
| 2022 | 9 | 23 | None | $2,532 |
| 2021 | 13 | 43 | None | $1,459 |
| 2020 | 10 | 25 | None | $1,445 |
| 2019 | 6 | 18 | None | $2,206 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Proclaim | $1,260 | 15 payments
|
| Medtronic | Kyphon Express II Kyphopak Tray | $871 | 13 payments
|
| SPR Therapeutics | Sprint Pns System | $762 | 4 payments
|
| Boston Scientific | General - Pain Management | $296 | 3 payments
|
| Globus Medical | Senza | $281 | 3 payments
|
| Si-Bone | None | $135 | 1 payment
|
See all 40 published payments
| Globus Medical | Meals · 2025-12-05 | Senza | $144 |
| Medtronic | Meals · 2025-12-02 | Inceptiv | $17 |
| Abbott Laboratories | Meals · 2025-11-24 | Proclaim | $174 |
| Si-Bone | Meals · 2025-11-19 | None | $135 |
| Abbott Laboratories | Meals · 2025-10-24 | Proclaim | $146 |
| Medtronic | Meals · 2025-10-20 | Inceptiv | $10 |
| SPR Therapeutics | Consulting · 2025-10-01 | Sprint Pns System | $378 |
| SPR Therapeutics | Travel · 2025-10-01 | Sprint Pns System | $124 |
| Abbott Laboratories | Meals · 2025-09-14 | Proclaim | $110 |
| SPR Therapeutics | Meals · 2025-09-06 | Sprint Pns System | $134 |
| Abbott Laboratories | Meals · 2025-09-04 | Eterna | $128 |
| SPR Therapeutics | Meals · 2025-08-15 | Sprint Pns System | $127 |
| Abbott Laboratories | Meals · 2025-08-11 | Proclaim | $158 |
| Medtronic | Meals · 2025-08-08 | Inceptiv | $14 |
| Medtronic | Meals · 2025-07-22 | Inceptiv | $71 |
| Medtronic | Meals · 2025-06-19 | Inceptiv | $18 |
| Boston Scientific | Meals · 2025-05-20 | General - Pain Management | $120 |
| Abbott Laboratories | Meals · 2025-05-20 | Proclaim | $21 |
| Globus Medical | Meals · 2025-05-06 | Senza | $68 |
| Globus Medical | Meals · 2025-05-06 | Senza | $69 |
| Boston Scientific | Meals · 2025-04-24 | Intracept | $30 |
| Medtronic | Meals · 2025-04-21 | Inceptiv | $8 |
| Boston Scientific | Meals · 2025-04-15 | General - Pain Management | $147 |
| Stryker | Meals · 2025-04-01 | Mild Device Kit | $122 |
| Medtronic | Meals · 2025-03-25 | Inceptiv | $103 |
| Medtronic | Meals · 2025-02-22 | Kyphon Express II Kyphopak Tray | $43 |
| Medtronic | Meals · 2025-02-22 | Kyphon Express II Kyphopak Tray | $54 |
| Medtronic | Travel · 2025-02-21 | Kyphon Express II Kyphopak Tray | $269 |
| Medtronic | Travel · 2025-02-21 | Kyphon Express II Kyphopak Tray | $44 |
| Medtronic | Meals · 2025-02-07 | Inceptiv | $68 |
| Medtronic | Meals · 2025-01-14 | Intellis Adaptivestim | $153 |
| Abbott Laboratories | Meals · 2025-01-02 | Octrode | $133 |
| Abbott Laboratories | Meals · 2025-01-02 | Proclaim | $39 |
| Abbott Laboratories | Meals · 2025-01-02 | Proclaim | $166 |
| Abbott Laboratories | Meals · 2025-01-02 | Proclaim | $13 |
| Abbott Laboratories | Meals · 2025-01-02 | Eterna | $42 |
| Abbott Laboratories | Meals · 2025-01-02 | Eterna | $40 |
| Abbott Laboratories | Meals · 2025-01-02 | Eterna | $23 |
| Abbott Laboratories | Meals · 2025-01-02 | Eterna | $20 |
| Abbott Laboratories | Meals · 2025-01-02 | Proclaim | $48 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,281
| Abbott Laboratories | Proclaim | $701 | 18 payments
|
| Saluda Medical Americas | Evoke | $580 | 10 payments
|
| Boston Scientific | Infinion 16 | $475 | 5 payments
|
| Medtronic | Intellis Adaptivestim | $143 | 1 payment
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $142 | 4 payments
|
| Avanos Medical | Standard Rf Disposables | $115 | 1 payment
|
| Vertos Medical | Mild Device Kit | $90 | 1 payment
|
| Vertex Pharmaceuticals | None | $34 | 1 payment
|
2023: $858
| Medtronic | Intellis Adaptivestim | $380 | 4 payments
|
| Saluda Medical Americas | Evoke Scs | $134 | 2 payments
|
| Vertos Medical | Mild Device Kit | $131 | 3 payments
|
| Abbott Laboratories | Proclaim | $118 | 3 payments
|
| Boston Scientific | None | $96 | 1 payment
|
2022: $2,532
| Abbott Laboratories | Proclaim | $2,200 | 13 payments
|
| Mml US | Reactiv8 | $110 | 1 payment
|
| Foundation Fusion Solutions | None | $87 | 1 payment
|
| Vertos Medical | Mild Device Kit | $51 | 2 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $20 | 1 payment
|
| Medtronic | Intellis Adaptivestim | $20 | 1 payment
|
| Relievant Medsystems | Intracept | $18 | 2 payments
|
| Abbvie | Ubrelvy | $14 | 1 payment
|
| AcelRx Pharmaceuticals | Dsuvia | $12 | 1 payment
|
2021: $1,459
| Relievant Medsystems | Intracept | $464 | 13 payments
|
| Boston Scientific | Vertiflex Superion | $231 | 4 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $203 | 6 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $128 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $91 | 5 payments
|
| Vertos Medical | Mild Device Kit | $81 | 4 payments
|
| Medtronic | Intellis | $79 | 2 payments
|
| Si-Bone | Ifuse Implant | $47 | 1 payment
|
| IBSA Pharma | Licart | $43 | 2 payments
|
| Almatica Pharma | Naprelan | $41 | 2 payments
|
| Gilead Sciences | None | $19 | 1 payment
|
| Ferring Pharmaceuticals | Euflexxa | $17 | 1 payment
|
| AbbVie | Ubrelvy | $16 | 1 payment
|
2020: $1,445
| Vertos Medical | Mild Device Kit | $946 | 9 payments
|
| Stimwave Technologies | Cfns Stimq Peripheral Nerve Stimulatorsystem | $165 | 6 payments
|
| Si-Bone | Ifuse Implant | $124 | 1 payment
|
| Boston Scientific | Vertiflex Superion | $88 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $37 | 2 payments
|
| Allergan | Ubrelvy | $28 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido | $17 | 1 payment
|
| Baudax Bio | Anjeso | $15 | 1 payment
|
| Medtronic USA | Intellis | $13 | 1 payment
|
| Fidia Pharma USA | Hymovis | $13 | 1 payment
|
2019: $2,206
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $1,470 | 13 payments
|
| Stimwave Technologies | None | $316 | 1 payment
|
| Pfizer | Vyndaqel | $116 | 1 payment
|
| Medtronic USA | Restore | $107 | 1 payment
|
| Amgen | Aimovig | $100 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $98 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 52.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1629335591
- Licence
- NY 282512, TX 282512, TX S9858Texas S9858: Delinquent - Incomplete Registration
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X); Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 2081P2900X (2081P2900X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2012-04-17
- NPI last updated
- 2025-01-13
- NPI record certified
- 2025-01-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 225 Front St, Binghamton, NY, 13905 · 750 Fish Creek Thoroughfare Ste 100, Montgomery, TX, 77316 · 20639 Kuykendahl Rd Ste 200, Spring, TX, 77379 · 6767 Lake Woodlands Dr Ste F, The Woodlands, TX, 77382